24 May 2013
Keywords: map, leaps, up, 900m, deal, az, anglo-swedish
Article | 12 January 2009
Anglo-Swedish drug major AstraZeneca has entered an exclusive worldwide agreement to develop and commercialize Unit Dose Budesonide, US firm
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
© 2013 thepharmaletter.com